Skip to main content

Gene editing breakthrough: CRISPR improves vision in clinical trial

By SciTech Daily  
   May 14, 2024

In a recent clinical trial, CRISPR gene editing was applied to 14 patients suffering from a form of inherited blindness. The treatment proved safe and resulted in measurable vision improvements in 11 of the participants. The trial, named BRILLIANCE, signifies a significant step forward in gene therapy for ocular diseases

Full story

Get the latest on healthcare leadership in your inbox.